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P Moore, A D Steele, G Lecatsas, JJ Alexander
Objective. To analyse adenovirus (Ad) numbers and types
associated with paediatric gastro-enteritis in South Africa
Setting. Gauteng, 1994-1996.
Metfwds. A total of 234 paediatric diarrhoeal stool samples
were screened for Ad using commercial enzyme-linked
iInmunosorbent assays (EUSAs). Adenoviral isolates were
typed, where possibie, using restriction enzyme analysis.
Results. Ad was detected in 23 (9.8%) specimens, of which 8
(34.8%) were found by subgroup F-specilic EUSA to contain
Ad40 or 41. Six of these isolates were typed and 2 could not
be typed. Of the remaining 15 specimens, 2 isolates had
restriction profiles that did not correspond with known Ads,
while 2were identified as Ad31 and 1 as a subgroup CAd.
The remaining 10 specimens negative for Ad40/41 were non-
cultivable and could not be typed.
Conclusions. The high percentage of non-eultivable Ads other
than Ad40/41 is unusual, and may possibly indicate the
prevalence of hexon variants of Ad40/41 or of emerging Ad
types in South Africa.
5 Aft Mi!i j 1998; 8& 1587-1592.
Diarrhoeal diseases are a major cause of death in infants and
young children in South Africa. In 19 6 gastro-enteritis was
estimated to account for 27.5% of the total number of infant
deaths. The most common aetiological agents of viral gastro-
enteritis are the rotaviruses and adenovirusesY
ThE' adenovirus (Ad) serotypes most frequently associated
with gastro-enteritis include those of subgenus A (types 12,18
and 31) and subgenus F (types 40 and 41)."s Subgenera A and F
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serotypes are therefore referred to as 'enteric' Ads based on
their shared tropism for the gastro-intestinal tract.'
In cell culture, Ad40 and Ad41 grow poorly (relative to other
serotypes) and are therefore referred to as 'fastidious' enteric
Ads (PEAds).' The defectiveness of FEAd growth in vitro makes
diagnosis of these viruses difficult. Types 40 and 41 are often
diagnosed by presumptive methods based on the presence of
large numbers of Ad particles in stool, as detected by electron
rnicroscopy, and the inability to culture these viruses in cell
lines that support the growth of conventional Ads.7
Ad40 and Ad41 have been propagated in Chang conjunctival
cells, Graharn 293 cells, A549 cells and PLC/PRF15 cells.
However, differences in susceptibility to virus growth in
different batches of the same cell line and variations in the
growth of different virus strains make diagnosis using cell
culture difficult.' The development of commercial ELISAs using
monoclonal antibodies directed against subgroup-specific
epitopes has facilitated diagnosis of Ad40/41 elsewhere,' but
their specificity for South African PEAd strains is unknown.
Ad31 has been increasingly isolated during the past decade,
and is.significantly associated with paediatric gastro-enteritis.4.6
The clinical features of Ad31 gastro-enteritis are
indistinguishable from those of Ad4O/41 gastro-enteritis." The
importance of Ad31 in paediatric gastro-enteritis in South
Africa is not known.
This study examined the numbers and types of Ads detected
in paediatric diarrhoeal specimens in South Africa.
MATERIALS AND METHODS
Cell lines
Chang conjunctival cells and the PLC/PRF/5 cell line were
kindly supplied by C T Tiemessen (Nationallnstitute for
Virology). Cells were cultured in minimal essential medium
(MEM) with Hepes salts and 5 - 10% fetal calf serum, at 37°C.
Minocyclin (2 pg/mlt penicillin (0.1 mg/ml) and streptomycin
(0.1 mg/ml) were incorporated in the culture medium.
Viruses
Paediatric diarrhoeal stool specimens were obtained from the
Medical University of Southern Africa, Ga-Rankuwa.
Specimens were screened for Ads using a commercially
available enzyme-linked imrnunosorbent assay (ELISA)
(Biotrin International Adenovirus Antigen ElA). Samples with
absorbances (450 nm) greater than 0.3 were regarded as
positive (the high value was used to reduce the possibility of
false positives). Ad-positive specimens were further screened
for the presence of subgroup F Ads by ELISA (Cambridge
Biotech Adenoclone - Type 40/41 ElA).
Infection of cells
Specimens were prepared as 10% weight/volume (w/v)
suspension in MEM without serum, vortexed for 1 minute,
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then clarified by centrifugation at 12 000 g for 5 minutes.
Clarified stool suspensions were inoculated onto duplicate
subconfluent cultures of Chang conjunctival cells and
PLC/PRF/5 cells, and incubated overnight at 37°C. Infected
cells were washed with phosphate buffered saline, then
maintained in MEM with 10% fetal calf serum.
Cells were harvested when maximum cytopathic effect (CPE)
was observed (or 3 weeks post-infection when no CPE was
observed), and subjected to three freeze-thaw cycles to release
virus. Virus growth was monitored by ELISA (Biotrin
International).
Extraction of virus from stool specimens
Virus was extracted directly from stool specimens by a
modification of the procedure described by Buitenwerf et aJ.9
Approximately 500 p1 faeces were suspended in 1 500 p1 of STE
buffer (Tris-HCI 50 mM, NaCl100 mM, EDTA 5 mM, pH 7.4),
and vortexed for 1 minute with glass beads (75 - 150 pm). The
suspension was clarified by centrifugation at 4 000 g for
10 minutes at 4°C. The supematanfwas extracted with an
equal volume of 1),2-trichloro-trillouro-ethane (Sigma) and
centrifuged at 4 000 g for 10 minutes at 20°e. The aqueous
layer was removed, and the virus precipitated by the addition
of polyethylene glycol 6 000 to a final concentration of 10%,
and O.5M NaCl. After precipitation for 2 hours at 4°C, the virus
was pelleted by centrifugation at 20000 g for 20 minutes at 4°C,
and was resuspended in 500 p1 STE buffer.
Extraction of virus from harvested cell supematant
Virus was extracted from infected cells after freeze-thawing
and clarification at 4 000 g for 10 minutes at 4°e. Five millilitres
of clarified supematant was extracted with 1,1,2-trichloro-
trillouro-ethane (Sigma) and the virus was precipitated using
the above method.
Extraction of viral DNA
The pelleted virus was resuspended in 500 p1 STE buffer.
Proteinase K and SDS were added to a final concentration of
250 pg/ml and 1% respectively, and the reaction incubated for
30 minutes at 37°C. Protein was extracted once with TE-
saturated phenol and once with phenol-eh1oroform (25:24:1
phenol: chloroform: isoamyl alcohol). Sodium acetate was
added to a final concentration of O.5M. Two volumes of
absolute ethanol were added, and the DNA precipitated
overnight at -70°C. The D A was pelleted by centrifugation at
20000 g for 30 minutes at O°C, then resuspended in 20 pl TE
buffer (pH 7.4).
DNA restriction analysis
Restriction analysis was performed with Sma J, Barn H1 and
Bgl IT (Boehringer) at a concentration of 1 U/pl. Restriction
proceeded at 37°C for 30 - 60 minutes in the recommended
buffers supplied with the enzymes. Agarose gel electrophoresis
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DISCUSSION
Fig. 1. Diagrammatic representation of 0.8% agarose gel
electrophoresis of Sma I restricted viral DNA. Lane 1 - molecular
weight marker O..DNA restricted with Hind Ill), Lane 2 - Ad40,
Lane 3 - Ad41, Lane 4 - untyped isoLate A, Lane 5 - untyped
isoLate B.
Ads have been associated with 3.1 - 13.5% of cases of paediatric
diarrhoea in studies from Asia, Europe, and orth and South
Amf-rica (Table m. The subgroup F Ads are reported to
comprise between 34.8% and 100% of these Ads. In previous
studies in South Africa, Ad40 and Ad41 were associated with
4.3 - 13.2% of paediatric gastro-enteritis cases,u.13 and were
found to be the predominant types of Ads associated with
diarrhoea (65.6%).
The number of Ads and specifically SUbgroup F Ads detected
in diarrhoeal stool specimens in this study is therefore
consistent with previous reports. However, the observation that
the subgroup F Ads in this study comprised only 34.8% of all
Ads detected in stools differs from previous reports. The
number of Ads that could not be typed (52.2%) also differs
significantly from reported numbers, suggesting the possibility
of a shift in the prevalence of specific Ad types in South Africa.
using Sma I was performed on each of these 4 isolates and on a
single non-eultivable isolate extracted directly from the stool
sample.
Two cultivable isolates were typed as Ad31 by restriction
analysis using Sma I, Bam HI and Bgl IT, and a single cultivable
isolate was identified by restriction analysis as belonging to
subgroup C, but was not typed.
Two isolates showed DNA banding profiles that did not
correspond to that of any known Ad type (Figs 1 and 2).'0.u
Electron microscopy was used to confirm the presence of Ad in
these isolates (Fig. 3). However, one of these isolates may
comprise part of a dual infection as the total DNA length
(4OkB) exceeds that of an Ad (Fig. 1, lane 5 and Fig. 2b).
The remaining isolates were non-cultivable in Chang
conjunctival and PLC/PRF/5 cell lines, and could therefore not
be typed. Extraction directly from stool specimens was
unsuccessful. These specimens were examined by electron












Ad 23/234* 9.8% of total
diarrhoea
Subgroup FAds 8/23 34.8% of Ads
Type 40 (by RFLP) 3/23 13.0%
Type 41 (by RFLP) 3/23 13.0%
Untypedt 2/23 8.7%
Subgroup A Ads
Type 31 2/23 8.7%
Subgroup CAds
Untyped 1/23 4.3%
Untyped (non-subgroup F) 12/23 52.2%
Unknown D A profiles by 2/23 8.7%
restriction analysis
o D A profilet 10/23 43.5%
Table I. Analysis of Ad numbers and types detected in stool
specimens
• Total number of dian:hoeal specimens screened by ELlSA.
tIsolates were non-cu1tivable and virus extraction from stool was unsuccessful.
RFlP = re;lrietion fragment length polymorphism-
RESULTS
A total of 234 paediatric diarrhoeal stool samples were
screened by the group-specific ELISA (Biotrin), of which 23
(9.8%) were found to be positive for Ad (Table I). These 23
samples were further screened using the subgroup F-specific
ELISA (Adenoclone).
Of the 23 samples, only 8 (34.8%) were found to be positive
for Ad40 and Ad41. Where sufficient sample was available,
D A was extracted directly from stool specimens. Where direct
extraction was impossible, samples were used to infect Chang
conjunctival and/or PLC/PRF/5 cells, and viral growth was
monitored by examination for CPE and/or group-specific
ELISA of tissue culture supematant.
Of the 8 specimens positive for Ad40/41, 3 isolates were
identified as Ad40, and 3 as Ad41 based on Sma I restriction
profiles. The remaining 2 isolates could not be typed.
Attempts to culture Ad from the 15 specimens negative for
Ad40 and Ad41 failed in all but 4 cases. Restriction analysis
was performed in 0.8 -1% agarose gels containing 0.5 pg/ml
ethidium bromide, using TEE buffer (45 mM Tris-Borate, 1 mM
EDTA), pH 8.0.
Transmission electron microscopy
Stool specimens were prepared as 10% (wIv) suspensions in
distilled water, and centrifuged at 12 000 g for 10 minutes. The
clarified suspension was ultracentrifuged at 53 000 g for
90 minutes. TIssue culture adapted virus was concentrated by
addition of PEG 6000 as described previously. The virus was
resuspended in distilled water, and stained with 3% w /v
phosphotungstic acid, pH 6.8. Samples were viewed under a








Fig. 2. Agarose gel electrophoresis (0.8%) of Sma I restricted viral DNA. Left: lane 1 - molecular weight marker (?.DNA restricted with Hind
Ill), lane 2 - untyped isolate A. Right: lane 1 - molecular weight marker (IDNA restricted with Hind Ill), lane 2 - untyped isolate B.
Fig. 3. Electron microscopy of PEG precipitated vinls (isolate A)
propagated in PLC/pRF/S cells.
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Two Ad isolates were identified by restriction analysis as
Ad31. This is, to our knowledge, the first report of Ad31 in
South Africa, although the association of Ad31 with gastro-
enteritis is well established elsewhere.'"
The isolation of a single subgroup C isolate is consistent with
other studies. Although subgroup C Ads have not been
aetiologically assodated with gastro-enteritis, Ads 1, 2 and 5
are occasionally recovered from stools.'""
The 10 non-cultivable specimens negative by Adenoclone
ELISA for Ad40/41 are unusual. Although Ads were detected
by electron microscopy in only 4 of the 10 isolates, it is possible
that viruses were excreted at levels too low to be detected by
electron microscopy in the remaining 6 specimens.
The Adenoclone immunoassay employs monoclonal
antibodies (MAbs) directed against type-specific epitopes on
Ad40 and Ad41 hexon, and therefore detects subgroup FAds."
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Table H. Reported occurrence of gastro-enteritis-associated Ads
%Adof % Ad4O/41 Percentage of total Ads
total of total
Country diarrhoea diarrhoea Ad4O/41 Ad31 Other types Untyped
Australia (1981 - 1992)'" 3.1 3.1 100 0 0 0
Sweden (1981)2 13.5 7.9 58.9 27* 14.3
Canada (1983 - 1986)' ND ND 54.9 17.8 25.2 2.1
Brazil (1988 - 1998)21 10 3.75 37.5 0 37.5 25
Canada (1988 _1992)1' 9.9 4.9 49 6.1 30.1 14.8
Guatemala (1987 -1988)22 ND 14.0 ND ND ND ND
South Africa (1985 - 1986)13 ND 13.2 ND ND ND ND
South Africa (1982 - 1983)!2 6.5 4.3 65.6 0 1.6 32.8
South Africa (1994 - 1996)t 9.8 3.4 34.8 8.7 4.2 52.2
• Includes 'conventional' Ad types 1 - 39.
t This study.
ND = not done.
The neutralisation epitopes of Ads are composed of serotype-
specific residues in 7 hypervariable regions (HVRs) in the
hexon region. These HVRs are subject to recombination and an
unusually high rate of single base mutations. IS The outer
surface of the hexon is thought to be a neutralisable
detenninant and is most prone to antigenic drift. Thus highly
specific MAbs to surface components of the hexon may be
susceptible to loss of reactivity with changes in epitopes under
immunological selection pressure.!'
The emergence of hexon variants has previously been shown
to compromise the value of existing immunoassaysy·18 Scott-
Taylor et atY identified several Ad41 strains that escaped
detection by an early version of the Adenoclone 40/41 kit
(Cambridge Bioscience). The modified kit now detects the
Ad41 strains circulating in North America,!7 but the emergence
of new variants remains a potential problem.'
The fastidiousness of 10 untyped Ad isolates in vitro suggests
that these could be subgroup F Ads. It is possible that variants
of Ad4O/41 prevalent in South Africa may have undergone
variations in that region of the hexon to which the MAbs used
in the Adenoclone kit are directed.1< They may therefore not be
reactive with those MAbs and so would not be detected by the
Adenoclone 40/41 kit.
Another possibility is that these non-eultivable and non-
Ad40/41 isolates are newly emerging Ad types. This is further
suggested by the isolation of 2 isolates with D A restriction
profiles that do not correspond to any known Ads.
Genetic variability withirI the Ad group is considerable. The
emergence of 7 new types (Ads 42 - 49), isolated almost
exclusively from AIDS patients, has been reported since the
mid-1980s. In addition to new serotypes and variants,
intertypic strains called intermediates have been described in
increasing numbers, particularly from AIDS patients. I '
Homologous recombination between closely related strains
or serotypes has consistently been proposed as the primary
evolutionary mechanism for Ads:' The genetic variability of
the Ads is further affected by the presence of HVRs in the
hexon region, and the possibility of illegitimate recombination
events (involving D TA of limited homology, with short direct
repeats at junctions) in such regions·'
o epidemiological studies of Ads in South Africa have been
performed since 1989.13 It is possible, given the extreme
variability of Ads, that previously unidentified fastidious Ads
have become increasingly prevalent in South Africa during the
past decade.
These results indicate that the use of either the Biotrin or the
Adenoclone ELISAs as diagnostic tools in South Africa may be
inappropriate. There appear to be significant differences
between the enteric Ads prevalent in South Africa and those
commonly reported worldwide. This indicates a need for
further characterisation of Ads associated with gastro-enteritis
in South Africa.
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TUMOURS - THE RED CROSS
WAR MEMORIAL CHILDREN'S
HOSPITAL EXPERIENCE, 1980 - 1996
J D Daubenton, P S Hartley, H Rode, C C Sinclair-Smith
Objective. To document the experience of Red Cross War
Memorial Children's Hospital in the treatment of
sacrococcygeal germ-eell tumours.
Patients. Twenty-seven patients with sacrococcygeal germ-eell
tumours were treated in our hospital from 1980 to 1996.
Design. A retrospective review of these patients' records was
undertaken.
Results. There were 19 female and 8 male patients. Seventeen
(63%) presented in the neonatal period, 13 on the first day of
life. Complete surgical resection of the tumour was achieved
in all patients with mature or immature teratomas (20
patients) and in 2 neonates with malignant tumours. The first
of these 2 neonates, with a malignant teratoma, was not given
chemotherapy and remains well 10 years later. The second,
with a yolk-sac tumour, also received no initial
chemotherapy. He relapsed at the age of 9 months and was
successfully treated with repeat excision and chemotherapy.
All 5 patients first diagnosed after the age of 1 year had
malignant tumours. These patients had incomplete surgical
resection (3) or biopsy only (2), and 3 were successfully
treated with chemotherapy. One patient relapsed with yolk-
sac tumour after initial complete resection cif a mature
teratoma. She was successfully treated with repeat surgery
and chemotherapy.
5 Afr Med [1998; 88: 1592-1594.
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